Coccidioidal Peritonitis: A Review of 17 Cases.
Royce H JohnsonRitika SharmaRupam SharmaValerie CivelliVishal NarangRasha KuranEllie J C GoldsteinStan DeresinskiAmber JonesAmin RamzanIrving PosalskiDena El-SayedGeorge R ThompsonCarlos D'AssumpcaoArash HeidariPublished in: Open forum infectious diseases (2022)
Coccidioidomycosis is the second most common endemic fungal infection in the United States. Prior descriptions of coccidioidal peritonitis include only single cases. We describe 17 new cases previously unreported from healthcare institutions in California. The majority of cases presented with nonspecific abdominal complaints. PubMed and Google Scholar were searched for additional case series and only single case reports and reviews of single cases were found. The diagnosis was confirmed by culture or histopathology and/or serology in each patient. All patients were treated with anti-fungal therapy. This case series demonstrates that coccidioidal peritonitis may be asymptomatic or present with only subtle abdominal symptoms. In a minority of our patients, the diagnosis was established incidentally during surgery. Based on this series, the overall outcome of coccidioidal peritonitis is favorable with long-term triazole treatment. The term cure is not usually used in disseminated coccidioidal disease because of the risk of late relapse.
Keyphrases
- end stage renal disease
- healthcare
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- minimally invasive
- preterm infants
- stem cells
- randomized controlled trial
- depressive symptoms
- bone marrow
- acute coronary syndrome
- atrial fibrillation
- percutaneous coronary intervention
- combination therapy